학술논문
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities
Document Type
article
Author
Coppé, Jean-Philippe; Mori, Miki; Pan, Bo; Yau, Christina; Wolf, Denise M; Ruiz-Saenz, Ana; Brunen, Diede; Prahallad, Anirudh; Cornelissen-Steijger, Paulien; Kemper, Kristel; Posch, Christian; Wang, Changjun; Dreyer, Courtney A; Krijgsman, Oscar; Lee, Pei Rong Evelyn; Chen, Zhongzhong; Peeper, Daniel S; Moasser, Mark M; Bernards, René; van ‘t Veer, Laura J
Source
Nature Cell Biology. 21(6)
Subject
Language
Abstract
Phosphorylation networks intimately regulate mechanisms of response to therapies. Mapping the phospho-catalytic profile of kinases in cells or tissues remains a challenge. Here, we introduce a practical high-throughput system to measure the enzymatic activity of kinases using biological peptide targets as phospho-sensors to reveal kinase dependencies in tumour biopsies and cell lines. A 228-peptide screen was developed to detect the activity of >60 kinases, including ABLs, AKTs, CDKs and MAPKs. Focusing on BRAFV600E tumours, we found mechanisms of intrinsic resistance to BRAFV600E-targeted therapy in colorectal cancer, including targetable parallel activation of PDPK1 and PRKCA. Furthermore, mapping the phospho-catalytic signatures of melanoma specimens identifies RPS6KB1 and PIM1 as emerging druggable vulnerabilities predictive of poor outcome in BRAFV600E patients. The results show that therapeutic resistance can be caused by the concerted upregulation of interdependent pathways. Our kinase activity-mapping system is a versatile strategy that innovates the exploration of actionable kinases for precision medicine.